• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Genetic susceptibility to toxic epidermal necrolysis.

作者信息

Roujeau J C, Huynh T N, Bracq C, Guillaume J C, Revuz J, Touraine R

出版信息

Arch Dermatol. 1987 Sep;123(9):1171-3.

PMID:3477129
Abstract

The pathophysiologic events leading to toxic epidermal necrolysis (TEN) remain unknown. With the idea of an immunologically mediated reaction occurring in predisposed subjects we performed HLA-A, -B and -DR typing in 44 patients surviving TEN. We observed a significant increase of only HLA-B12, previously found associated with ocular complications of Stevens-Johnson syndrome. When patients were stratified according to the drugs involved as causes for their TEN, we found other HLA phenotypes associated with B12, varying with each category of drugs. Sulfonamide-related cases of TEN were linked to A29, B12, and DR7, while oxicam-related cases of TEN were linked to A2 and B12. These results suggest that a genetic background, related to the major histocompatibility complex, may contribute to severe blistering drug reactions.

摘要

相似文献

1
Genetic susceptibility to toxic epidermal necrolysis.
Arch Dermatol. 1987 Sep;123(9):1171-3.
2
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.一项关于与五种高危药物相关的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症中HLA - B的欧洲研究。
Pharmacogenet Genomics. 2008 Feb;18(2):99-107. doi: 10.1097/FPC.0b013e3282f3ef9c.
3
HLA phenotypes and bullous cutaneous reactions to drugs.人类白细胞抗原表型与药物引起的大疱性皮肤反应。
Tissue Antigens. 1986 Oct;28(4):251-4. doi: 10.1111/j.1399-0039.1986.tb00491.x.
4
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.在泰国人群中,HLA - B*5801与别嘌醇诱发的史蒂文斯 - 约翰逊综合征及中毒性表皮坏死松解症之间存在强关联。
Pharmacogenet Genomics. 2009 Sep;19(9):704-9. doi: 10.1097/FPC.0b013e328330a3b8.
5
Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.伐地考昔引起的与史蒂文斯-约翰逊综合征及中毒性表皮坏死松解症不同的皮肤不良反应。
Arch Dermatol. 2007 Jun;143(6):711-6. doi: 10.1001/archderm.143.6.711.
6
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.药物使用与史蒂文斯-约翰逊综合征或中毒性表皮坏死松解症的风险。
N Engl J Med. 1995 Dec 14;333(24):1600-7. doi: 10.1056/NEJM199512143332404.
7
Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.共享和受限的 T 细胞受体使用对于卡马西平诱导的史蒂文斯-约翰逊综合征至关重要。
J Allergy Clin Immunol. 2011 Dec;128(6):1266-1276.e11. doi: 10.1016/j.jaci.2011.08.013. Epub 2011 Sep 14.
8
The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).87例中毒性表皮坏死松解症(莱尔综合征)中的致病药物。
Arch Dermatol. 1987 Sep;123(9):1166-70.
9
Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症患者在皮肤脱落前可溶性Fas配体水平升高。
J Allergy Clin Immunol. 2008 Nov;122(5):992-1000. doi: 10.1016/j.jaci.2008.06.013. Epub 2008 Aug 9.
10
Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.药物作为儿童史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的危险因素:一项汇总分析。
Pediatrics. 2009 Feb;123(2):e297-304. doi: 10.1542/peds.2008-1923. Epub 2009 Jan 19.

引用本文的文献

1
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCAR.具有共享肽结合特异性的HLA - B等位基因决定了复方新诺明诱导的严重皮肤不良反应的全球风险。
medRxiv. 2025 May 28:2025.05.28.25328237. doi: 10.1101/2025.05.28.25328237.
2
COVID-19 and severe cutaneous allergic reactions to sulfonamides.新型冠状病毒肺炎与磺胺类药物严重皮肤过敏反应
Allergy Asthma Proc. 2024 Nov 1;45(6):e93-e100. doi: 10.2500/aap.2024.45.240086.
3
Paraneoplastic dermatomyositis and Stevens-Johnson syndrome related to immunotherapy.
免疫治疗相关副肿瘤性皮肌炎和史蒂文斯-约翰逊综合征。
Immunotherapy. 2024;16(11):709-714. doi: 10.1080/1750743X.2024.2362107. Epub 2024 Jun 18.
4
Genotypic and Phenotypic Characteristics of Co-Trimoxazole-Induced Cutaneous Adverse Reactions.复方新诺明诱导的皮肤不良反应的表型和基因型特征。
Dermatology. 2023;239(6):966-975. doi: 10.1159/000534342. Epub 2023 Oct 4.
5
Toxic Epidermal Necrolysis, A Serious Side Effect of Tenoxicam Use: A Case Report.使用替诺昔康的严重副作用——中毒性表皮坏死松解症:一例报告
Healthcare (Basel). 2023 Aug 3;11(15):2195. doi: 10.3390/healthcare11152195.
6
Investigation of Four Cases of Stevens-Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020.海地大规模药物治疗磺胺多辛-乙胺嘧啶和伯氨喹期间,4 例 Stevens-Johnson 综合征病例调查,2020 年。
Am J Trop Med Hyg. 2023 May 1;108(6):1140-1144. doi: 10.4269/ajtmh.22-0625. Print 2023 Jun 7.
7
Association of Human Leukocyte Antigen Alleles with Carbamazepine- or Lamotrigine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in an Iranian Population: A Case-control Study.伊朗人群中人类白细胞抗原等位基因与卡马西平或拉莫三嗪诱导的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的关联:一项病例对照研究。
Iran J Med Sci. 2023 Jan;48(1):70-76. doi: 10.30476/IJMS.2022.91192.2241.
8
Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.药物基因组学中的人类白细胞抗原(HLA)检测
Methods Mol Biol. 2022;2547:21-45. doi: 10.1007/978-1-0716-2573-6_2.
9
Clinical Manifestations and Genetic Influences in Sulfonamide-Induced Hypersensitivity.磺胺类药物所致超敏反应的临床表现及遗传影响
Drug Healthc Patient Saf. 2022 Jul 21;14:113-124. doi: 10.2147/DHPS.S347522. eCollection 2022.
10
The Immunogenetics of Cutaneous Drug Reactions.皮肤药物反应的免疫遗传学。
Adv Exp Med Biol. 2022;1367:411-431. doi: 10.1007/978-3-030-92616-8_17.